General anesthesia, pneumoperitoneum under gastrectomy
Conditions
Interventions
Landiolol groups: surgery to perform continuously administered intravenously at a safe administration rate 1mcg/kg/min obtained from the results of pilot study on the dose of landiolol. Postoperativel
Sponsors
Fujita Health University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, It does not matter the gender at 65 years of age or elder. 2, Patients in the evaluation of using the two or more preoperative Revised Cardiac Risk Index(RCRI)
Exclusion criteria
Exclusion criteria: 1. Patients contraindicated of landiolol. (Patients with cardiogenic shock, patients with diabetic acidosis, atrioventricular block II degrees or more), bradyarrhythmia patients such as sick sinus syndrome, patients with pulmonary hypertension and right heart failure, patients with congestive heart failure, patients with untreated pheochromocytoma, and patients with a history of hypersensitivity to landiolol) 2. Patients with emergency surgery 3. Patients with heart rate of 40 times/min or less 4. patients with low blood pressure (systolic blood pressure less than 80mmHg) 5. Patients with severe heart failure (NYHA classification III,IV) 6.Patients assessed by anesthetist preoperative patients participating in the study are determined to be unsuitable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of supra ventricular arrhythmia in 72 hours from the start of administration | — |
Countries
Japan
Contacts
Public ContactKoichi Suda
Fujita Health University Division of Upper GI, Department of Surgery
Outcome results
None listed